LYSARC,
Academic partner
of Lymphoma
Clinical Research

Research partnership

LYSARC has a long and successful experience of research partnerships, especially with leading pharmaceutical and biotechnology companies developing medicines and diagnostic tools for lymphoma.

Recherche PartenarialeThese partnerships are in accordance with the Charter of the relationship between the French Oncology Cooperative Groups (Groupes Coopéarateurs en Oncologie) coordination to which LYSARC belongs, and industry.

Through its participation in the CALYM consortium, LYSARC is encouraged by the French government to develop its partnering research to contribute to the development of solutions to unmet medical needs in the diagnosis and treatment of lymphoma.